Search results
Mesoblast's (MESO) GVHD Drug BLA Gets FDA Priority Tag, Stock Up
Zacks via Yahoo News· 1 year agoMesoblast (MESO) announces the FDA acceptance for review of the resubmitted biological license...
Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
Zacks via Yahoo News· 3 months agoMesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate,...
Mia Hamm's brother died following complications from a bone marrow transplant. Now the soccer star...
Yahoo Life· 10 months agoMia Hamm shares her connection to the bone marrow transplant community. (Getty Images) Getty Images...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo News· 1 month agoA month has gone by since the last earnings report for Incyte (INCY). Shares have added about 7.5%...
Bone Marrow Mix-Up Led to Leukemia Patient’s ‘Horrific’ Death: Lawsuit
The Daily Beast via Yahoo News· 4 months agoPhoto Illustration by Luis G. Rendon/The Daily Beast/GettyA leukemia patient was mistakenly given a...
Talaris (TALS) Down on Patient Death From Renal Transplant Study
Zacks via Yahoo News· 2 years agoTalaris Therapeutics (TALS) reports a patient death from its late-stage study evaluating its...
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo News· 3 months agoIncyte's (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and...
Incyte's (INCY) Earnings and Revenues Surpass Estimates in Q2
Zacks via Yahoo News· 2 years agoIncyte's (INCY) earnings and revenues trump estimates in the second quarter of 2022. The company...
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Zacks via Yahoo News· 3 months agoSyndax Pharmaceuticals (SNDX) groundbreaking menin inhibitor, revumenib, receives FDA priority...
Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo News· 2 years agoIncyte INCY has had a good run so far this year. It is one of the few biotech stocks that has...